ATRIANCE
ATRIANCE
Approved
DIN Number
02299925
Drug Class
Human
Market Date
Jan 17, 2008
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02299925
AIG Number0152299001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BB07 NELARABINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NELARABINEActive
Strength: 5 MG / ML
Monograph: NELARABINE